De Novo Biologics Design: AI-Enabled Approaches to Deliver Better Biologics by Design

• Shifting from screening-based discovery towards biologics by design through AI momentum and applications
• Exploring how real impact today is accelerating design-make-test cycles and reducing experimental iteration
• Recognizing that success requires integrated AI platforms that combine generative models, predictive models, and experimental feedback

Speakers:

Shipra Malhotra

Associate Director, AI/ML Biologics

Takeda